Learn More
Log In
Sign Up
Prescription Drug Affordability Board | Midpage
Collections
Maryland Code
Health—General
Title 21
2c
Prescription Drug Affordability Board
State of Maryland
21-2C-01
Definitions
21-2C-02
Establishment; purpose
21-2C-03
Membership
21-2C-04
Prescription Drug Affordability Stakeholder Council
21-2C-05
Disclosure of conflict of interest
21-2C-06
Acceptance of gifts or donations
21-2C-07
Study of aspects of pharmaceutical distribution and payment; report
21-2C-08
Identifying prescription drug products that create affordability challenges for State health care system and patients
21-2C-09
Cost review of prescription drug products identified in § 21-2C-08
21-2C-10
Trade secrets; confidential and proprietary information
21-2C-11
Annual fee; Prescription Drug Affordability Fund
21-2C-12
Enforcement of subtitle
21-2C-13
Process for setting upper payment limits for prescription drug products that lead to affordability challenges
21-2C-14
Upper payment limits
21-2C-15
Appeals
21-2C-16
Upper payment limits for purchases and payor reimbursements of prescription drug products that have led or will lead to affordability challenges